Daratumumab in Combination with Lenalidomide Plus Dexamethasone Results in Persistent Natural Killer (NK) Cells with a Distinct Phenotype and Expansion of Effector Memory T-Cells in Pollux, a Phase 3 Randomized Study

N W Van De Donk ,Hugo Ceulmans ,Homer Adams ,Jakub Krejcik ,Nizar J Bahlis ,Torben Plesner ,Jordan M Schecter ,Saad Z Usmani ,Berris Van Kessel-Welmers ,Henk M Lokhorst ,Christopher Chiu ,Frederik Stevenaert ,Yann Abraham ,Koen Van Der Borght ,Tuna Mutis ,Tineke Casneuf ,Sagar Lonial ,Tina Smets ,Amy Axel ,Greet Vanhoof ,Hervé Avet‐Loiseau

doi:10.1182/blood.v130.suppl_1.3124.3124

Daratumumab in Combination with Lenalidomide Plus Dexamethasone Results in Persistent Natural Killer (NK) Cells with a Distinct Phenotype and Expansion of Effector Memory T-Cells in Pollux, a Phase 3 Randomized Study

N W Van De Donk , Hugo Ceulmans + Show 19 more

https://doi.org/10.1182/blood.v130.suppl_1.3124.3124

Copy DOI

Export

Save

Cite

Journal: Blood	Publication Date: Jun 25, 2021
Citations: 1

Affiliation: Amsterdam UMC Location VUmc, Janssen (Belgium), Janssen (United States), Vejle Sygehus, University of Southern Denmark, University of Calgary, Baker Hughes (Canada), Carolinas Healthcare System, Levine Cancer Institute, Emory University, Hôpital Rangueil

#Research Funding #Natural Killer Cells #Advisory Committees #Speakers Bureau #Entity's Board #Daratumumab #Board Of Directors #Van Der Borght #Circulating Natural Killer Cells #Higher Proportion Of CD8

Abstract
Full-Text
Similar Papers

Abstract

Listen

Daratumumab in Combination with Lenalidomide Plus Dexamethasone Results in Persistent Natural Killer (NK) Cells with a Distinct Phenotype and Expansion of Effector Memory T-Cells in Pollux, a Phase 3 Randomized Study

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Blood

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Daratumumab in Combination with Lenalidomide Plus Dexamethasone Results in Persistent Natural Killer (NK) Cells with a Distinct Phenotype and Expansion of Effector Memory T-Cells in Pollux, a Phase 3 Randomized Study